Companion diagnostics and more

Siemens and LabCorp to co-develop clinical tests

Possibilities to co-develop new clinical diagnostic tests for companion diagnostics, metabolic syndrome, oncology and diabetes, are being explored by Siemens Healthcare and Laboratory Corporation of America Holdings (LabCorp).

Companion diagnostics are tests designed to identify the suitability between patients and a particular drug therapy. The tests can be used in personalised medicine to improve the safety and efficacy of therapeutic drugs and in some cases, may help determine optimal dosing for individual patients.
Metabolic syndrome is becoming more common and is characterised by a person having multiple risk factors that may include high blood pressure, heart disease, obesity and diabetes, among others. It is estimated that more than 50 million people are affected by this syndrome in the USA alone.
LabCorp is a reference laboratory with over 220,000 clients in the US. The new strategic cooperation, said Dave Hickey, Senior Vice President Strategic Planning and Business Development, Siemens Healthcare Diagnostics, ‘establishes a framework that gives both companies the opportunity to offer new diagnostic tests to laboratories, physicians and their patients more quickly and effectively than either could do alone.’
Myla P Lai-Goldman MD, executive vice president, chief scientific officer and medical director for LabCorp, added that the firm is ‘… excited about this strategic collaboration and its impact on our companion diagnostics efforts. Alliances, such as this between developers and providers of new tests, are critical in translating emerging biomarkers from research into clinical practice.’

01.07.2008

Read all latest stories

Related articles

Photo

Sponsored • Earlier disease prediction and identification

The potential of AI in routine blood testing

It’s widely known that more than 70% of today’s medical decisions involve the results of laboratory tests, but the insights clinicians derive from these tests today may only be scratching the…

Photo

Sponsored • Siemens Naeotom Alpha

First CT scanner with photon-counting technology

Conventional CT imaging has reached its technical limitations: Resolution can only be improved by small margins and dose cannot be reduced significantly: Photon-counting technology enables drastic…

Photo

Sponsored • Photon-counting CT scanner

No detours, more detail

For the Siemens Healthineers team developing new and ever higher performing computed tomographs is daily fare. But when they introduced their most recent CT system an unusual sense of pride was…

Related products

Subscribe to Newsletter